-
Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762
25 Nov 2025 20:07 GMT
… Corp. – November 25, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a … Chairman of the Board, Phio Pharmaceuticals. “We are deeply grateful to … important milestone.”
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is …
-
Net profit of Ozon Pharmaceuticals increased by 50 in 9 months%
25 Nov 2025 20:17 GMT
… of the SPO.
Ozon Pharmaceuticals Group is a Russian … all pharmaceutical niches. Ozon Pharmaceuticals has 16 operating production sites … . Shares of PJSC Ozon Pharmaceuticals (OZPH) have been traded … net profit of Ozon Pharmaceuticals according to RAS for …
-
Ozon Pharmaceuticals plans to pay dividends for 9 months in the amount of 315.276 million rubles
25 Nov 2025 20:16 GMT
… Directors of PJSC Ozon Pharmaceuticals recommended that the shareholders… per share.
Ozon Pharmaceuticals Group is a Russian … all pharmaceutical niches. Ozon Pharmaceuticals has 16 operating production … Shares of PJSC Ozon Pharmaceuticals (OZPH) have been …
-
TLX LAWSUIT ALERT: Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline
25 Nov 2025 21:17 GMT
… investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." … on behalf of Telix Pharmaceuticals Ltd. investors who were … pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form? … a loss in Telix Pharmaceuticals Ltd. during the relevant …
-
Novartis Pharmaceuticals Canada Inc. announces Dimitri Gitas as new Country President
25 Nov 2025 17:21 GMT
… Group/Novartis Pharmaceuticals Canada Inc.)
MONTREAL — Novartis Pharmaceuticals Canada Inc. (Novartis …
-
<![CDATA[Otsuka Pharmaceuticals Submits NDA for Centanafadine to Treat ADHD in Children]]>
25 Nov 2025 17:07 GMT
Otsuka Pharmaceuticals announced on November 25, 2025, … Children, Adolescents, and Adults. Otsuka Pharmaceuticals. November 25, 2025. https:…
-
Mizuho Lowers Price Target on Apellis Pharmaceuticals (APLS) Amid Ongoing Eye Disease Therapy Challenges
25 Nov 2025 15:01 GMT
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) … its Neutral rating for Apellis Pharmaceuticals Inc. (NASDAQ:APLS) … quarter gain in injections. Apellis Pharmaceuticals Inc. (NASDAQ:APLS) … than the consensus estimates. Apellis Pharmaceuticals Inc. (NASDAQ:APLS) …
-
Agios Pharmaceuticals (AGIO) Upgraded After Mixed Sickle Cell Data and Pending Thalassemia Catalyst
25 Nov 2025 15:00 GMT
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) ranks among … 20, Leerink Partners upgraded Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) from Market … compared to rival luspatercept. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is a …
-
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
25 Nov 2025 14:50 GMT
… class action lawsuit against Telix Pharmaceuticals Limited (“Telix” or “the Company …
-
Rhythm Pharmaceuticals initiated with Buy at Citi on Imcivree's potential
25 Nov 2025 14:29 GMT
alexslRhythm Pharmaceuticals (RYTM) initiated with a Buy…
About
© 1995-2025